Valemetostat tosylate (DS3201; DS3201b), the tosylate salt of Valemetostat, is an investigational and orally bioavailable dual EZH1/2 inhibitor with potential anticancer activity. It is being studied in clinical trial for the treatment of patients with relapsed/refractory adult T-cell leukemia/lymphoma (ATL).

纯度：≥98%

CAS：1809336-93-3